22.10
Stickoxid-Signalweg
Stickstoffmonoxid (NO), ein anorganisches Gas, fungiert in den meisten tierischen und pflanzlichen Geweben als starker sekundärer Botenstoff. NO diffu…
Stickstoffmonoxid oder NO ist ein gasförmiges Signalmolekül und ein einzigartiger zweiter Botenstoff, der Prozesse wie die Entspannung der glatten Muskulatur, die Neurotransmission und die visuelle Wahrnehmung vermittelt.
Acetylcholin-gebundene GPCRs stimulieren PLC-β, um die IP3-Produktion zu induzieren, die die Freisetzung von Kalzium auslöst.
Calciumionen binden Calmodulin zu einem Komplex, der die NO-Synthase aktiviert. Das Enzym produziert in den Endothelzellen NO, das in die benachbarten glatten Muskelzellen diffundiert, um auf sie einzuwirken.
NO bindet und aktiviert die Guanylylcyclase, um zyklisches GMP zu produzieren, das die Proteinkinase G oder PKG aktiviert.
PKG aktiviert eine Phosphatase, die Myosin-Leichtketten dephosphoryliert. Dies induziert die Faltung der Myosinköpfe und dissoziiert sie von den Aktinfilamenten.
PKG hemmt auch IP3-gesteuerte Kalziumkanäle und reduziert dadurch die zytosolische Kalziumkonzentration. Niedrige Kalziumspiegel inaktivieren Myosin-Leichtkettenkinasen und verhindern so den Wiederaufbau von Aktin-Myosin und die Muskelkontraktion.
Die glatte Muskulatur entspannt sich nun, so dass sich die Blutgefäße erweitern und die Durchblutung erhöhen kann.
View the full transcript and gain access to JoVE Core videos
Q1: How does nitric oxide function as a second messenger in cells?
Nitric oxide is a gaseous signaling molecule that diffuses out of producing cells and enters neighboring cells to generate downstream responses. NO binds and activates guanylyl cyclase, which converts GTP to cyclic GMP. This rapid increase in cGMP levels triggers protein kinase G activation, initiating the cellular response within seconds. NO's short half-life of 2-30 seconds allows it to act locally on adjacent cells.
Q2: What role does calmodulin play in nitric oxide production?
Calcium ions released from intracellular stores bind calmodulin to form a complex that activates NO synthase. This enzyme catalyzes NO production through deamination of the amino acid arginine. The calmodulin-dependent signaling pathway is essential for initiating nitric oxide synthesis in response to acetylcholine-bound GPCRs and subsequent IP3-mediated calcium release.
Q3: How does protein kinase G cause smooth muscle relaxation?
Protein kinase G activates a phosphatase that dephosphorylates myosin light chains, causing myosin heads to fold and dissociate from actin filaments. PKG also inhibits IP3-gated calcium channels, reducing cytosolic calcium concentration. Low calcium inactivates myosin light chain kinases, preventing actin-myosin reassembly and muscle contraction, resulting in smooth muscle relaxation.
Q4: Why does nitric oxide cause blood vessels to dilate?
NO diffuses from endothelial cells into neighboring smooth muscle cells, where it activates guanylyl cyclase to produce cyclic GMP. This triggers protein kinase G activation, which disassembles the actin-myosin contractile machinery. Smooth muscle relaxation allows blood vessels to dilate, increasing blood flow to tissues. This mechanism is crucial for regulating vascular tone and blood pressure.
Q5: What are the three isoforms of NO synthase and where are they found?
Endothelial NOS (eNOS) is found in endothelial cells lining blood vessels. Neuronal NOS (nNOS) is present in nerve and muscle cells. Inducible NOS (iNOS) is produced by macrophages upon exposure to various pathogens. Each isoform catalyzes NO production through arginine deamination in different tissue contexts and physiological conditions.
Q6: How do phosphodiesterase inhibitors like Viagra affect cGMP levels?
cGMP phosphodiesterase normally degrades cyclic GMP, balancing its cytosolic levels. Drugs like Viagra inhibit this enzyme, causing cGMP to remain elevated for prolonged periods. Sustained cGMP levels maintain smooth muscle relaxation in penile blood vessels, increasing blood flow and enabling erection. This mechanism demonstrates how feedback regulation of signaling molecules controls physiological responses.
Q7: How is nitroglycerine used to treat angina?
Nitroglycerine has been used since the 1860s to treat angina, a severe chest pain caused by improper blood flow to the heart muscle. The drug metabolizes into nitric oxide once inside the body. NO then dilates blood vessels, increasing blood flow to the heart and relieving chest pain. This therapeutic application demonstrates NO's critical role in regulating vascular function and tissue perfusion.